| negative regulation of metabolic process (GO:0009892) | 1.93 | 3 | DRD5, DRD4, MECP2 |
| positive regulation of metabolic process (GO:0009893) | 1.74 | 3 | DRD5, DRD4, MECP2 |
| regulation of metabolic process (GO:0019222) | 1.02 | 3 | DRD5, DRD4, MECP2 |
| regulation of cellular biosynthetic process (GO:0031326) | 1.38 | 3 | DRD5, MECP2, DRD4 |
| positive regulation of cellular metabolic process (GO:0031325) | 1.81 | 3 | DRD5, DRD4, MECP2 |
| learning (GO:0007612) | 4.85 | 3 | DRD5, MECP2, DRD4 |
| behavior (GO:0007610) | 3.47 | 3 | DRD5, MECP2, DRD4 |
| learning or memory (GO:0007611) | 4.33 | 3 | DRD5, MECP2, DRD4 |
| signaling (GO:0023052) | 3.25 | 3 | DRD5, MECP2, DRD4 |
| regulation of signaling (GO:0023051) | 1.72 | 3 | DRD5, DRD4, MECP2 |
| regulation of cell communication (GO:0010646) | 1.73 | 3 | DRD5, DRD4, MECP2 |
| regulation of biological process (GO:0050789) | 0.45 | 3 | DRD5, DRD4, MECP2 |
| single-organism process (GO:0044699) | 0.48 | 3 | DRD5, MECP2, DRD4 |
| regulation of primary metabolic process (GO:0080090) | 1.08 | 3 | DRD5, DRD4, MECP2 |
| biological regulation (GO:0065007) | 0.39 | 3 | DRD5, MECP2, DRD4 |
| response to organic cyclic compound (GO:0014070) | 3.07 | 3 | DRD5, DRD4, MECP2 |
| neurological system process (GO:0050877) | 2.64 | 3 | DRD5, DRD4, MECP2 |
| positive regulation of biological process (GO:0048518) | 1.2 | 3 | DRD5, MECP2, DRD4 |
| negative regulation of biological process (GO:0048519) | 1.33 | 3 | DRD5, DRD4, MECP2 |
| regulation of biological quality (GO:0065008) | 1.68 | 3 | DRD5, DRD4, MECP2 |
| multicellular organismal process (GO:0032501) | 1.45 | 3 | DRD5, MECP2, DRD4 |
| regulation of nucleobase-containing compound metabolic process (GO:0019219) | 1.43 | 3 | DRD5, DRD4, MECP2 |
| regulation of cellular metabolic process (GO:0031323) | 1.07 | 3 | DRD5, MECP2, DRD4 |
| cellular process (GO:0009987) | 0.26 | 3 | DRD5, DRD4, MECP2 |
| regulation of biosynthetic process (GO:0009889) | 1.37 | 3 | DRD5, MECP2, DRD4 |
| regulation of cellular process (GO:0050794) | 0.5 | 3 | DRD5, MECP2, DRD4 |
| response to stress (GO:0006950) | 1.8 | 3 | DRD5, MECP2, DRD4 |
| associative learning (GO:0008306) | 5.44 | 3 | DRD5, DRD4, MECP2 |
| single-organism cellular process (GO:0044763) | 0.65 | 3 | DRD5, DRD4, MECP2 |
| regulation of nitrogen compound metabolic process (GO:0051171) | 1.36 | 3 | DRD5, DRD4, MECP2 |
| metabolic process (GO:0008152) | 0.58 | 3 | DRD5, DRD4, MECP2 |
| chemical synaptic transmission (GO:0007268) | 3.98 | 3 | DRD5, MECP2, DRD4 |
| cell-cell signaling (GO:0007267) | 3.35 | 3 | DRD5, MECP2, DRD4 |
| response to chemical (GO:0042221) | 1.98 | 3 | DRD5, DRD4, MECP2 |
| modulation of synaptic transmission (GO:0050804) | 4.09 | 3 | DRD5, DRD4, MECP2 |
| response to organic substance (GO:0010033) | 2.2 | 3 | DRD5, MECP2, DRD4 |
| system process (GO:0003008) | 2.3 | 3 | DRD5, DRD4, MECP2 |
| single organism signaling (GO:0044700) | 3.25 | 3 | DRD5, DRD4, MECP2 |
| single-multicellular organism process (GO:0044707) | 1.78 | 3 | DRD5, MECP2, DRD4 |
| single-organism behavior (GO:0044708) | 3.79 | 3 | DRD5, DRD4, MECP2 |
| response to stimulus (GO:0050896) | 1.22 | 3 | DRD5, DRD4, MECP2 |
| cognition (GO:0050890) | 4.2 | 3 | DRD5, DRD4, MECP2 |
| cellular metabolic process (GO:0044237) | 0.69 | 3 | DRD5, MECP2, DRD4 |
| cell communication (GO:0007154) | 3.04 | 3 | DRD5, MECP2, DRD4 |
| anterograde trans-synaptic signaling (GO:0098916) | 3.98 | 3 | DRD5, DRD4, MECP2 |
| synaptic signaling (GO:0099536) | 3.98 | 3 | DRD5, MECP2, DRD4 |
| trans-synaptic signaling (GO:0099537) | 3.98 | 3 | DRD5, DRD4, MECP2 |
| negative regulation of cellular process (GO:0048523) | 1.41 | 3 | DRD5, MECP2, DRD4 |
| positive regulation of cellular process (GO:0048522) | 1.3 | 3 | DRD5, DRD4, MECP2 |
| regulation of phosphate metabolic process (GO:0019220) | 2.35 | 2 | DRD5, DRD4 |
| memory (GO:0007613) | 5.13 | 2 | DRD4, MECP2 |
| cation homeostasis (GO:0055080) | 3.46 | 2 | DRD5, DRD4 |
| calcium ion homeostasis (GO:0055074) | 3.97 | 2 | DRD5, DRD4 |
| inorganic ion homeostasis (GO:0098771) | 3.43 | 2 | DRD5, DRD4 |
| organic cyclic compound metabolic process (GO:1901360) | 1.26 | 2 | DRD4, MECP2 |
| positive regulation of macromolecule metabolic process (GO:0010604) | 1.81 | 2 | DRD4, MECP2 |
| dopamine receptor signaling pathway (GO:0007212) | 6.26 | 2 | DRD5, DRD4 |
| positive regulation of molecular function (GO:0044093) | 2.23 | 2 | DRD5, DRD4 |
| negative regulation of molecular function (GO:0044092) | 2.74 | 2 | DRD5, DRD4 |
| cellular homeostasis (GO:0019725) | 3.23 | 2 | DRD5, DRD4 |
| social behavior (GO:0035176) | 5.9 | 2 | DRD4, MECP2 |
| intraspecies interaction between organisms (GO:0051703) | 5.9 | 2 | DRD4, MECP2 |
| regulation of cyclase activity (GO:0031279) | 5.32 | 2 | DRD5, DRD4 |
| multi-organism behavior (GO:0051705) | 5.6 | 2 | DRD4, MECP2 |
| multi-organism process (GO:0051704) | 2.65 | 2 | MECP2, DRD4 |
| organonitrogen compound metabolic process (GO:1901564) | 2.32 | 2 | DRD4, MECP2 |
| regulation of macromolecule metabolic process (GO:0060255) | 1.08 | 2 | DRD4, MECP2 |
| response to organonitrogen compound (GO:0010243) | 3.2 | 2 | DRD5, DRD4 |
| regulation of purine nucleotide biosynthetic process (GO:1900371) | 4.8 | 2 | DRD5, DRD4 |
| multicellular organismal response to stress (GO:0033555) | 5.67 | 2 | MECP2, DRD4 |
| signal transduction (GO:0007165) | 1.28 | 2 | DRD5, DRD4 |
| regulation of membrane potential (GO:0042391) | 3.89 | 2 | DRD4, MECP2 |
| negative regulation of biosynthetic process (GO:0009890) | 2.47 | 2 | DRD4, MECP2 |
| positive regulation of biosynthetic process (GO:0009891) | 2.29 | 2 | DRD5, MECP2 |
| regulation of synaptic plasticity (GO:0048167) | 4.78 | 2 | DRD5, MECP2 |
| nitrogen compound metabolic process (GO:0006807) | 1.13 | 2 | DRD4, MECP2 |
| chemical homeostasis (GO:0048878) | 2.97 | 2 | DRD5, DRD4 |
| adenylate cyclase-modulating G-protein coupled receptor signaling pathway (GO:0007188) | 4.78 | 2 | DRD5, DRD4 |
| behavioral defense response (GO:0002209) | 6.43 | 2 | MECP2, DRD4 |
| synaptic transmission, dopaminergic (GO:0001963) | 7.02 | 2 | DRD5, DRD4 |
| regulation of molecular function (GO:0065009) | 1.78 | 2 | DRD5, DRD4 |
| G-protein coupled receptor signaling pathway (GO:0007186) | 2.64 | 2 | DRD5, DRD4 |
| G-protein coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187) | 4.6 | 2 | DRD5, DRD4 |
| locomotory behavior (GO:0007626) | 4.53 | 2 | DRD4, MECP2 |
| regulation of catalytic activity (GO:0050790) | 1.97 | 2 | DRD5, DRD4 |
| transport (GO:0006810) | 1.51 | 2 | MECP2, DRD4 |
| defense response (GO:0006952) | 2.78 | 2 | DRD4, MECP2 |
| regulation of multicellular organismal process (GO:0051239) | 1.87 | 2 | MECP2, DRD4 |
| regulation of postsynaptic membrane potential (GO:0060078) | 5.72 | 2 | DRD4, MECP2 |
| establishment of localization (GO:0051234) | 1.48 | 2 | DRD4, MECP2 |
| secretion (GO:0046903) | 3.38 | 2 | DRD4, MECP2 |
| response to nitrogen compound (GO:1901698) | 3.12 | 2 | DRD5, DRD4 |
| regulation of lyase activity (GO:0051339) | 5.3 | 2 | DRD5, DRD4 |
| response to amphetamine (GO:0001975) | 6.36 | 2 | DRD5, DRD4 |
| positive regulation of multicellular organismal process (GO:0051240) | 2.49 | 2 | DRD4, MECP2 |
| organic hydroxy compound metabolic process (GO:1901615) | 3.84 | 2 | MECP2, DRD4 |
| regulation of synapse structure or activity (GO:0050803) | 4.77 | 2 | DRD5, MECP2 |
| response to radiation (GO:0009314) | 3.69 | 2 | MECP2, DRD4 |
| ion homeostasis (GO:0050801) | 3.42 | 2 | DRD5, DRD4 |
| metal ion homeostasis (GO:0055065) | 3.61 | 2 | DRD5, DRD4 |
| positive regulation of synaptic transmission (GO:0050806) | 5.07 | 2 | DRD4, MECP2 |
| positive regulation of signaling (GO:0023056) | 2.41 | 2 | DRD4, MECP2 |
| response to light stimulus (GO:0009416) | 4.08 | 2 | MECP2, DRD4 |
| positive regulation of cell communication (GO:0010647) | 2.41 | 2 | DRD4, MECP2 |
| response to amine (GO:0014075) | 5.88 | 2 | DRD5, DRD4 |
| negative regulation of catalytic activity (GO:0043086) | 3.0 | 2 | DRD5, DRD4 |
| positive regulation of catalytic activity (GO:0043085) | 2.4 | 2 | DRD5, DRD4 |
| behavioral fear response (GO:0001662) | 6.43 | 2 | DRD4, MECP2 |
| response to endogenous stimulus (GO:0009719) | 2.79 | 2 | DRD5, DRD4 |
| divalent inorganic cation homeostasis (GO:0072507) | 3.9 | 2 | DRD5, DRD4 |
| cellular divalent inorganic cation homeostasis (GO:0072503) | 3.96 | 2 | DRD5, DRD4 |
| regulation of cAMP biosynthetic process (GO:0030817) | 5.01 | 2 | DRD5, DRD4 |
| regulation of cAMP metabolic process (GO:0030814) | 4.88 | 2 | DRD5, DRD4 |
| regulation of protein metabolic process (GO:0051246) | 1.93 | 2 | DRD4, MECP2 |
| adult locomotory behavior (GO:0008344) | 5.3 | 2 | MECP2, DRD4 |
| regulation of protein modification process (GO:0031399) | 2.32 | 2 | DRD4, MECP2 |
| developmental process (GO:0032502) | 1.36 | 2 | DRD4, MECP2 |
| response to abiotic stimulus (GO:0009628) | 2.8 | 2 | MECP2, DRD4 |
| cellular metal ion homeostasis (GO:0006875) | 3.75 | 2 | DRD5, DRD4 |
| cellular calcium ion homeostasis (GO:0006874) | 4.01 | 2 | DRD5, DRD4 |
| cellular aromatic compound metabolic process (GO:0006725) | 1.3 | 2 | DRD4, MECP2 |
| cellular ion homeostasis (GO:0006873) | 3.57 | 2 | DRD5, DRD4 |
| cellular cation homeostasis (GO:0030003) | 3.6 | 2 | DRD5, DRD4 |
| regulation of cyclic nucleotide metabolic process (GO:0030799) | 4.69 | 2 | DRD5, DRD4 |
| cellular chemical homeostasis (GO:0055082) | 3.4 | 2 | DRD5, DRD4 |
| regulation of cellular protein metabolic process (GO:0032268) | 1.99 | 2 | DRD4, MECP2 |
| regulation of nucleotide biosynthetic process (GO:0030808) | 4.79 | 2 | DRD5, DRD4 |
| regulation of cyclic nucleotide biosynthetic process (GO:0030802) | 4.85 | 2 | DRD5, DRD4 |
| positive regulation of cellular biosynthetic process (GO:0031328) | 2.3 | 2 | DRD5, MECP2 |
| negative regulation of cellular biosynthetic process (GO:0031327) | 2.49 | 2 | MECP2, DRD4 |
| negative regulation of cellular metabolic process (GO:0031324) | 2.01 | 2 | MECP2, DRD4 |
| homeostatic process (GO:0042592) | 2.61 | 2 | DRD5, DRD4 |
| fear response (GO:0042596) | 6.36 | 2 | DRD4, MECP2 |
| neuron-neuron synaptic transmission (GO:0007270) | 5.74 | 2 | DRD5, DRD4 |
| regulation of adenylate cyclase activity (GO:0045761) | 5.51 | 2 | DRD5, DRD4 |
| organic substance metabolic process (GO:0071704) | 0.63 | 2 | MECP2, DRD4 |
| organic substance transport (GO:0071702) | 2.15 | 2 | MECP2, DRD4 |
| positive regulation of nucleobase-containing compound metabolic process (GO:0045935) | 2.35 | 2 | DRD5, MECP2 |
| negative regulation of nucleobase-containing compound metabolic process (GO:0045934) | 2.55 | 2 | DRD4, MECP2 |
| positive regulation of phosphate metabolic process (GO:0045937) | 2.78 | 2 | DRD5, DRD4 |
| positive regulation of phosphorus metabolic process (GO:0010562) | 2.78 | 2 | DRD5, DRD4 |
| regulation of phosphorus metabolic process (GO:0051174) | 2.35 | 2 | DRD5, DRD4 |
| single-organism transport (GO:0044765) | 2.18 | 2 | DRD4, MECP2 |
| negative regulation of nitrogen compound metabolic process (GO:0051172) | 2.47 | 2 | MECP2, DRD4 |
| positive regulation of nitrogen compound metabolic process (GO:0051173) | 2.29 | 2 | DRD5, MECP2 |
| localization (GO:0051179) | 1.4 | 2 | DRD4, MECP2 |
| single-organism localization (GO:1902578) | 2.09 | 2 | DRD4, MECP2 |
| response to oxygen-containing compound (GO:1901700) | 2.57 | 2 | DRD5, MECP2 |
| adult behavior (GO:0030534) | 4.79 | 2 | DRD4, MECP2 |
| regulation of purine nucleotide metabolic process (GO:1900542) | 4.41 | 2 | DRD5, DRD4 |
| anatomical structure development (GO:0048856) | 1.58 | 2 | MECP2, DRD4 |
| response to lipid (GO:0033993) | 3.11 | 2 | MECP2, DRD4 |
| regulation of nucleotide metabolic process (GO:0006140) | 4.38 | 2 | DRD5, DRD4 |